The incidence of nephrolithiasis in patients on KD ranges from 3 to 10% (233)
Changes in the levels of both circulating biomarkers were correlated with the TMAO levels (rho = 0.568, p = 0.002
Tirzepatide is a prescription dual GIP/GLP-1 receptor agonist that reduces body weight by slowing gastric emptying, suppressing appetite, and improving insulin sensitivity
IV therapy delivers vitamins, minerals, amino acids, and fluids directly into your bloodstream, producing close to 100% absorption compared with 20 to 50% from an oral vitamin
Each form has its own absorption rate and level of tolerance, so selecting the right one can influence how well it works for your body
Smanjuje propusnost crijeva i potie regeneraciju epitelnih stanica crijevne sluznice reguliranjem signalnog puta NF-B